Login / Signup

HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature.

Laurent MathiotGuillaume HerbreteauSiméon RobinCharlotte FenatJaafar BennounaChristophe BlanquartMarc Guillaume DenisElvire Pons-Tostivint
Published in: Current oncology (Toronto, Ont.) (2022)
-mutant tumours and should be explored in NSCLC patients.
Keyphrases
  • prognostic factors
  • small cell lung cancer
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • advanced non small cell lung cancer